SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,049,000 | -15.6% | 38,500 | -26.7% | 1.38% | -18.4% |
| Q1 2019 | $8,350,000 | +141.1% | 52,500 | +144.2% | 1.70% | +43.1% |
| Q1 2018 | $3,463,000 | +250.5% | 21,500 | +258.3% | 1.19% | +210.5% |
| Q4 2017 | $988,000 | +5.7% | 6,000 | -60.0% | 0.38% | +42.0% |
| Q3 2017 | $935,000 | +67.9% | 15,000 | +114.3% | 0.27% | +37.9% |
| Q2 2017 | $557,000 | -12.8% | 7,000 | -22.2% | 0.20% | -37.7% |
| Q1 2017 | $639,000 | +36.8% | 9,000 | +12.5% | 0.31% | +30.4% |
| Q4 2015 | $467,000 | -80.6% | 8,000 | -75.8% | 0.24% | -77.9% |
| Q2 2015 | $2,409,000 | – | 33,000 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |